

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.31752006 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.31752006 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.27952661 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.27952661 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.27952661 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.27952661 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.27952661 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 6.27952661 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.03258903 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.02489379 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.66894776 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 5.26315205 |
| 13 | detection of other organism (GO:0098543) | 5.22765886 |
| 14 | response to peptidoglycan (GO:0032494) | 5.14917180 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.11384843 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.05132201 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.89567806 |
| 18 | cellular extravasation (GO:0045123) | 4.89070437 |
| 19 | detection of bacterium (GO:0016045) | 4.88581155 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.77934446 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.74600800 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.60816858 |
| 23 | microglial cell activation (GO:0001774) | 4.59670634 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.51385307 |
| 25 | neutrophil activation (GO:0042119) | 4.50293055 |
| 26 | respiratory burst (GO:0045730) | 4.45973241 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.42812077 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 4.37331696 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.33107832 |
| 30 | leukocyte aggregation (GO:0070486) | 4.30977079 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.30476224 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.23175432 |
| 33 | response to host immune response (GO:0052572) | 4.23175432 |
| 34 | neutrophil mediated immunity (GO:0002446) | 4.22147810 |
| 35 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.11855583 |
| 36 | detection of biotic stimulus (GO:0009595) | 4.10083925 |
| 37 | macrophage activation (GO:0042116) | 4.09225481 |
| 38 | granulocyte activation (GO:0036230) | 4.09042927 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.05448573 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 4.02779500 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.97837616 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.95573747 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.87768461 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 3.87141053 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.83823126 |
| 46 | response to host (GO:0075136) | 3.83823126 |
| 47 | response to host defenses (GO:0052200) | 3.83823126 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.81716101 |
| 49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.76533619 |
| 50 | response to interleukin-15 (GO:0070672) | 3.75929990 |
| 51 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.72319882 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.72178470 |
| 53 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.68321265 |
| 54 | regulation of mast cell activation (GO:0033003) | 3.60405475 |
| 55 | myeloid leukocyte mediated immunity (GO:0002444) | 3.58087786 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.56912511 |
| 57 | regulation of leukocyte degranulation (GO:0043300) | 3.52017586 |
| 58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.51872273 |
| 59 | cellular response to interleukin-15 (GO:0071350) | 3.43865027 |
| 60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.38462369 |
| 61 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.36970806 |
| 62 | positive regulation of mast cell degranulation (GO:0043306) | 3.36970806 |
| 63 | leukocyte degranulation (GO:0043299) | 3.36016419 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 3.35652205 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.34960498 |
| 66 | regulation of B cell differentiation (GO:0045577) | 3.32591341 |
| 67 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.28646897 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.27746633 |
| 69 | positive regulation of B cell differentiation (GO:0045579) | 3.27218596 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 3.20650651 |
| 71 | defense response to protozoan (GO:0042832) | 3.19930509 |
| 72 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.19183291 |
| 73 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.18508759 |
| 74 | B cell mediated immunity (GO:0019724) | 3.17717620 |
| 75 | activated T cell proliferation (GO:0050798) | 3.13453897 |
| 76 | negative regulation of phagocytosis (GO:0050765) | 3.12437152 |
| 77 | cellular response to type I interferon (GO:0071357) | 3.10754418 |
| 78 | type I interferon signaling pathway (GO:0060337) | 3.10754418 |
| 79 | regulation of regulated secretory pathway (GO:1903305) | 3.10750338 |
| 80 | response to type I interferon (GO:0034340) | 3.08715256 |
| 81 | germinal center formation (GO:0002467) | 3.08651316 |
| 82 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.08638655 |
| 83 | negative regulation of interleukin-6 production (GO:0032715) | 3.07637249 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06893166 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04038269 |
| 86 | myeloid leukocyte activation (GO:0002274) | 3.02582409 |
| 87 | negative thymic T cell selection (GO:0045060) | 3.01810756 |
| 88 | dendritic cell migration (GO:0036336) | 3.00922069 |
| 89 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99094173 |
| 90 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.98632897 |
| 91 | positive regulation of interferon-alpha production (GO:0032727) | 2.97482951 |
| 92 | positive thymic T cell selection (GO:0045059) | 2.96966589 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94711304 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.93888800 |
| 95 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93656087 |
| 96 | negative T cell selection (GO:0043383) | 2.92889722 |
| 97 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.91990768 |
| 98 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.91620779 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91265138 |
| 100 | neutrophil chemotaxis (GO:0030593) | 2.90921190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71735570 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.99797180 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.52331807 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.91458852 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.90409482 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.43861350 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42211929 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.37815675 |
| 9 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.92939448 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88747352 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88077612 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.84350442 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.78916137 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.78773093 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.76479954 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.75696455 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71599661 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65222562 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53469037 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52206208 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48294877 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.34886410 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.25252822 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.22422194 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20036079 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.19164669 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17861633 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15234139 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13559946 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11308644 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07049474 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 2.05526131 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.01336188 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.98660709 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93623695 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85416943 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.80056414 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79135001 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75115950 |
| 40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74553144 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72757262 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71810438 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66514307 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.64598756 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63355732 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62884727 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62595245 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.57889125 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53139712 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50922596 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45110288 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.44201000 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42264470 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38479086 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37597662 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37507949 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37171598 |
| 58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34503203 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34361522 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34224119 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33908845 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31875128 |
| 63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30406573 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29412774 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28289050 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28104181 |
| 67 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26792578 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26385636 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22944345 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22297095 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21818275 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20082801 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19836593 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19640463 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19126251 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18312289 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17466225 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16910773 |
| 79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15224578 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08957729 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08654708 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05057560 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04477321 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02748205 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02620191 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02075395 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98851583 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97355607 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95015156 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94473691 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94169633 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90576463 |
| 93 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89556022 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85048463 |
| 95 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.84682403 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81336407 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77610982 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77023130 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73085582 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70064273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.19367091 |
| 2 | MP0003436_decreased_susceptibility_to | 4.37292343 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.80476837 |
| 4 | MP0003303_peritoneal_inflammation | 3.76216652 |
| 5 | MP0002419_abnormal_innate_immunity | 3.33996876 |
| 6 | MP0005025_abnormal_response_to | 2.96150264 |
| 7 | MP0005671_abnormal_response_to | 2.95725679 |
| 8 | MP0009785_altered_susceptibility_to | 2.90313245 |
| 9 | MP0001800_abnormal_humoral_immune | 2.88556481 |
| 10 | MP0006082_CNS_inflammation | 2.82850289 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.81604993 |
| 12 | MP0001790_abnormal_immune_system | 2.81184778 |
| 13 | MP0005387_immune_system_phenotype | 2.81184778 |
| 14 | MP0000685_abnormal_immune_system | 2.78111697 |
| 15 | MP0002723_abnormal_immune_serum | 2.60868553 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.55678877 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.53335701 |
| 18 | MP0001819_abnormal_immune_cell | 2.53170471 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.38620129 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.32605434 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.27895783 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.25853555 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.12240616 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.11605515 |
| 25 | MP0008260_abnormal_autophagy | 2.06526384 |
| 26 | MP0003828_pulmonary_edema | 2.04589416 |
| 27 | MP0002405_respiratory_system_inflammati | 2.03119321 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.88917683 |
| 29 | MP0002132_abnormal_respiratory_system | 1.88512464 |
| 30 | MP0000716_abnormal_immune_system | 1.88118013 |
| 31 | MP0002398_abnormal_bone_marrow | 1.86824163 |
| 32 | MP0009278_abnormal_bone_marrow | 1.83439942 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.77782233 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.69485680 |
| 35 | MP0009764_decreased_sensitivity_to | 1.65173157 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.59704836 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.58257891 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.55804704 |
| 39 | MP0002722_abnormal_immune_system | 1.55042670 |
| 40 | MP0004947_skin_inflammation | 1.55025243 |
| 41 | MP0004883_abnormal_blood_vessel | 1.54824901 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.52702074 |
| 43 | MP0003866_abnormal_defecation | 1.50748322 |
| 44 | MP0008469_abnormal_protein_level | 1.49612624 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.48809372 |
| 46 | MP0002429_abnormal_blood_cell | 1.47197356 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.42481557 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.40519455 |
| 49 | MP0004381_abnormal_hair_follicle | 1.38336501 |
| 50 | MP0005310_abnormal_salivary_gland | 1.37765379 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.35903259 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.35903259 |
| 53 | MP0003075_altered_response_to | 1.32570958 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.32102382 |
| 55 | MP0005451_abnormal_body_composition | 1.29691218 |
| 56 | MP0003690_abnormal_glial_cell | 1.28999634 |
| 57 | MP0000858_altered_metastatic_potential | 1.27558603 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.24861895 |
| 59 | MP0001851_eye_inflammation | 1.24149445 |
| 60 | MP0005164_abnormal_response_to | 1.21111607 |
| 61 | MP0004510_myositis | 1.07508508 |
| 62 | MP0000343_altered_response_to | 1.01960418 |
| 63 | MP0002166_altered_tumor_susceptibility | 0.97648815 |
| 64 | MP0005166_decreased_susceptibility_to | 0.96630260 |
| 65 | MP0001986_abnormal_taste_sensitivity | 0.93275594 |
| 66 | MP0000604_amyloidosis | 0.91472023 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 0.90961738 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.90562260 |
| 69 | MP0001853_heart_inflammation | 0.90065048 |
| 70 | MP0008004_abnormal_stomach_pH | 0.89600448 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.89284770 |
| 72 | MP0005390_skeleton_phenotype | 0.89147602 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.87722817 |
| 74 | MP0003448_altered_tumor_morphology | 0.87169004 |
| 75 | MP0009763_increased_sensitivity_to | 0.87085207 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.85682716 |
| 77 | MP0001663_abnormal_digestive_system | 0.83230307 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.75276138 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.72902639 |
| 80 | MP0004130_abnormal_muscle_cell | 0.66613197 |
| 81 | MP0003045_fibrosis | 0.65891614 |
| 82 | MP0008874_decreased_physiological_sensi | 0.64886825 |
| 83 | MP0003795_abnormal_bone_structure | 0.64655107 |
| 84 | MP0000249_abnormal_blood_vessel | 0.64348475 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62576801 |
| 86 | MP0002933_joint_inflammation | 0.61781397 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.61082296 |
| 88 | MP0002928_abnormal_bile_duct | 0.59420018 |
| 89 | MP0000490_abnormal_crypts_of | 0.58518018 |
| 90 | MP0005083_abnormal_biliary_tract | 0.58359653 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.57612766 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.56936311 |
| 93 | MP0001873_stomach_inflammation | 0.54507232 |
| 94 | MP0002006_tumorigenesis | 0.54231740 |
| 95 | MP0002133_abnormal_respiratory_system | 0.53909565 |
| 96 | MP0005388_respiratory_system_phenotype | 0.53909565 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.53222249 |
| 98 | MP0003878_abnormal_ear_physiology | 0.52252881 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.52252881 |
| 100 | MP0004484_altered_response_of | 0.50956919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.78224218 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.42529962 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.42193051 |
| 4 | Myositis (HP:0100614) | 6.13560834 |
| 5 | Orchitis (HP:0100796) | 5.78788350 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.65111786 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.49417202 |
| 8 | Optic neuritis (HP:0100653) | 5.49417202 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.28289215 |
| 10 | Stomatitis (HP:0010280) | 5.22956960 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.90147887 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.41349874 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.28158304 |
| 14 | Obstructive lung disease (HP:0006536) | 4.28158304 |
| 15 | Recurrent skin infections (HP:0001581) | 4.26183107 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 4.21993749 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 4.21396105 |
| 18 | Meningitis (HP:0001287) | 4.02699809 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.02204679 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.96628821 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.90968072 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.90968072 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.86008085 |
| 24 | Encephalitis (HP:0002383) | 3.83210904 |
| 25 | Hypochromic microcytic anemia (HP:0004840) | 3.77466836 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.69884553 |
| 27 | Gingivitis (HP:0000230) | 3.61090784 |
| 28 | Urticaria (HP:0001025) | 3.55264356 |
| 29 | Increased IgE level (HP:0003212) | 3.54666048 |
| 30 | Vasculitis (HP:0002633) | 3.43955207 |
| 31 | Prolonged bleeding time (HP:0003010) | 3.31619262 |
| 32 | Hemoptysis (HP:0002105) | 3.28851978 |
| 33 | Episodic fever (HP:0001954) | 3.26432244 |
| 34 | Chest pain (HP:0100749) | 3.25986603 |
| 35 | Hypochromic anemia (HP:0001931) | 3.22534160 |
| 36 | Amyloidosis (HP:0011034) | 3.07115140 |
| 37 | Cellulitis (HP:0100658) | 3.06011878 |
| 38 | Pulmonary infiltrates (HP:0002113) | 3.05151165 |
| 39 | T lymphocytopenia (HP:0005403) | 3.02171528 |
| 40 | Gingival bleeding (HP:0000225) | 3.00074106 |
| 41 | Leukocytosis (HP:0001974) | 2.98061453 |
| 42 | Arterial thrombosis (HP:0004420) | 2.95068532 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.93726525 |
| 44 | Peritonitis (HP:0002586) | 2.89978811 |
| 45 | Epistaxis (HP:0000421) | 2.80039535 |
| 46 | Anorexia (HP:0002039) | 2.79701012 |
| 47 | Pulmonary embolism (HP:0002204) | 2.77127999 |
| 48 | Recurrent viral infections (HP:0004429) | 2.72925539 |
| 49 | Pustule (HP:0200039) | 2.69303673 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.63341999 |
| 51 | Abnormality of T cells (HP:0002843) | 2.60208154 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.58198879 |
| 53 | Petechiae (HP:0000967) | 2.56339310 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.55612016 |
| 55 | Granulocytopenia (HP:0001913) | 2.53613311 |
| 56 | Osteomyelitis (HP:0002754) | 2.53406494 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.48982980 |
| 58 | Gangrene (HP:0100758) | 2.44657015 |
| 59 | Microcytic anemia (HP:0001935) | 2.44243933 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.44178751 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.44178751 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.44178751 |
| 63 | Increased IgM level (HP:0003496) | 2.43357033 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.40847509 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35900206 |
| 66 | Sepsis (HP:0100806) | 2.32186227 |
| 67 | Abnormality of the endocardium (HP:0004306) | 2.22205158 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.20298243 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.17547241 |
| 70 | Vertigo (HP:0002321) | 2.17485078 |
| 71 | Abnormality of the peritoneum (HP:0002585) | 2.17146792 |
| 72 | Eosinophilia (HP:0001880) | 2.16715520 |
| 73 | Loss of speech (HP:0002371) | 2.16270851 |
| 74 | Glomerulopathy (HP:0100820) | 2.14212336 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12852656 |
| 76 | Lymphopenia (HP:0001888) | 2.09114672 |
| 77 | Purpura (HP:0000979) | 2.08735578 |
| 78 | Increased serum ferritin (HP:0003281) | 2.06800932 |
| 79 | Keratitis (HP:0000491) | 2.06453351 |
| 80 | Hepatosplenomegaly (HP:0001433) | 2.05052954 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.04385230 |
| 82 | Acne (HP:0001061) | 2.04330236 |
| 83 | Colitis (HP:0002583) | 2.03403911 |
| 84 | Skin ulcer (HP:0200042) | 2.02835020 |
| 85 | Cheilitis (HP:0100825) | 2.02483406 |
| 86 | Polyneuropathy (HP:0001271) | 2.00919115 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 1.98310867 |
| 88 | Abnormality of the pericardium (HP:0001697) | 1.96880101 |
| 89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94951680 |
| 90 | Premature loss of primary teeth (HP:0006323) | 1.94000374 |
| 91 | Acute hepatic failure (HP:0006554) | 1.92230153 |
| 92 | Viral hepatitis (HP:0006562) | 1.91722903 |
| 93 | Agammaglobulinemia (HP:0004432) | 1.88618910 |
| 94 | Abnormal platelet volume (HP:0011876) | 1.88216465 |
| 95 | Slow saccadic eye movements (HP:0000514) | 1.87990434 |
| 96 | Hematochezia (HP:0002573) | 1.85240666 |
| 97 | Skin rash (HP:0000988) | 1.84955902 |
| 98 | Recurrent pneumonia (HP:0006532) | 1.82883063 |
| 99 | Amaurosis fugax (HP:0100576) | 1.82857976 |
| 100 | Abnormality of eosinophils (HP:0001879) | 1.82023981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.14861858 |
| 2 | BLK | 3.56084207 |
| 3 | MAP4K1 | 3.32816966 |
| 4 | IRAK4 | 3.18649398 |
| 5 | MAP2K3 | 3.10183956 |
| 6 | TYK2 | 2.82459580 |
| 7 | FES | 2.78673577 |
| 8 | CSK | 2.78224573 |
| 9 | ERN1 | 2.59082090 |
| 10 | TNK2 | 2.45186065 |
| 11 | GRK6 | 2.18555474 |
| 12 | ZAP70 | 2.12704230 |
| 13 | EPHB1 | 1.94837587 |
| 14 | FGR | 1.90139106 |
| 15 | BTK | 1.88785557 |
| 16 | TXK | 1.87540119 |
| 17 | PRPF4B | 1.86480671 |
| 18 | MAP3K3 | 1.82836772 |
| 19 | MAP3K11 | 1.82826679 |
| 20 | HCK | 1.80088708 |
| 21 | SYK | 1.79588552 |
| 22 | JAK3 | 1.74309087 |
| 23 | TAOK1 | 1.72388157 |
| 24 | TAOK3 | 1.70194020 |
| 25 | MAP3K14 | 1.56103992 |
| 26 | IKBKE | 1.50901097 |
| 27 | LYN | 1.49189774 |
| 28 | JAK2 | 1.47447145 |
| 29 | CSF1R | 1.39198386 |
| 30 | MAP3K13 | 1.34974465 |
| 31 | YES1 | 1.32182816 |
| 32 | TBK1 | 1.24612145 |
| 33 | KIT | 1.24067093 |
| 34 | KSR2 | 1.23036993 |
| 35 | JAK1 | 1.23009996 |
| 36 | LCK | 1.20557868 |
| 37 | MAP3K1 | 1.19121305 |
| 38 | ITK | 1.13773772 |
| 39 | TEC | 1.13720529 |
| 40 | SIK3 | 1.12750227 |
| 41 | IRAK1 | 1.07520422 |
| 42 | MARK2 | 1.05511478 |
| 43 | TGFBR2 | 1.03913231 |
| 44 | MATK | 1.00268372 |
| 45 | MARK3 | 0.97356253 |
| 46 | IRAK2 | 0.94763090 |
| 47 | TAOK2 | 0.92501024 |
| 48 | BMPR2 | 0.90485019 |
| 49 | PDK1 | 0.90109184 |
| 50 | STK10 | 0.89428549 |
| 51 | CDK19 | 0.87623996 |
| 52 | IKBKB | 0.86201531 |
| 53 | MAP3K6 | 0.82964202 |
| 54 | PTK6 | 0.81146650 |
| 55 | PRKD2 | 0.78939852 |
| 56 | SIK2 | 0.76555487 |
| 57 | PDPK1 | 0.75021831 |
| 58 | PIK3CG | 0.71498908 |
| 59 | MAP3K2 | 0.71140583 |
| 60 | LRRK2 | 0.70890521 |
| 61 | MAP3K7 | 0.70105787 |
| 62 | PTK2B | 0.69826061 |
| 63 | FYN | 0.68039617 |
| 64 | MAP2K4 | 0.67577822 |
| 65 | MAP3K5 | 0.65621886 |
| 66 | GRK7 | 0.65588255 |
| 67 | TESK2 | 0.63934827 |
| 68 | MAP2K6 | 0.61320454 |
| 69 | PRKCQ | 0.61222641 |
| 70 | STK11 | 0.60144925 |
| 71 | MAPK12 | 0.59126269 |
| 72 | DAPK2 | 0.59001776 |
| 73 | DYRK1B | 0.58565408 |
| 74 | EPHA3 | 0.58092294 |
| 75 | SGK3 | 0.56733387 |
| 76 | CDC42BPA | 0.54979442 |
| 77 | MAPK7 | 0.53259921 |
| 78 | HIPK2 | 0.49368757 |
| 79 | TRIB3 | 0.46783052 |
| 80 | RAF1 | 0.46286727 |
| 81 | KSR1 | 0.44702431 |
| 82 | SGK2 | 0.43288804 |
| 83 | PIM1 | 0.42330170 |
| 84 | RPS6KC1 | 0.41520962 |
| 85 | RPS6KL1 | 0.41520962 |
| 86 | FGFR3 | 0.40074932 |
| 87 | NLK | 0.39757010 |
| 88 | RET | 0.39346407 |
| 89 | CAMKK2 | 0.38459596 |
| 90 | RPS6KA6 | 0.38355294 |
| 91 | STK38 | 0.36895890 |
| 92 | MAPKAPK2 | 0.35475838 |
| 93 | PRKCZ | 0.31771820 |
| 94 | PRKG2 | 0.29802360 |
| 95 | CAMKK1 | 0.28945730 |
| 96 | ABL1 | 0.28160852 |
| 97 | PRKCD | 0.27907838 |
| 98 | WNK1 | 0.26212224 |
| 99 | MOS | 0.25364978 |
| 100 | DYRK3 | 0.24698648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.17360092 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14954313 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.99126274 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31563844 |
| 5 | Tuberculosis_Homo sapiens_hsa05152 | 2.30906342 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.29232343 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.24623573 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21013958 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.15246678 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09367742 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.08624045 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.07438418 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.00414708 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.95850876 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85774581 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.74316008 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73728575 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.72470789 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.70521754 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.69409376 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.65231273 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63799945 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61544086 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59470591 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.57003934 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56866814 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53555863 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53371584 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.43871705 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43521180 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38640444 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38419927 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36968651 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32811146 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32554814 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31808035 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.29205128 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27191979 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.24671507 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22845008 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21179472 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.16914187 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13016987 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12961928 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.07464141 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.04749508 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01873373 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.01132303 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.97208020 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.95191496 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90751227 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87256069 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86785488 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86264972 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.85160920 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81478834 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79306262 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79250100 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77972372 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76552739 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.76473786 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75360608 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75084015 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74928674 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74523954 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72805820 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71618057 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70103652 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66100980 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65890625 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63057441 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63040636 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62484241 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62444687 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.62115246 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60896905 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59729624 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59183009 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59006807 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56885532 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56871603 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56471818 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52688278 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51298490 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50750905 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49829087 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47979606 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45940237 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44986900 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44239150 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43834023 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43767398 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.43227845 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43006492 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42832085 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42706992 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41474936 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40648030 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36570830 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35778444 |

